Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
Attention for sex in COVID-19 trials: a review of regulatory dossiers
de Vries, S. T., Starokozhko, V., Schellens, I. M. M., Wijnans, L., Enzmann, H., Cavaleri, M. & Mol, P. G. M., 2022, In: BMJ Global Health. 7, 3, 9 blz., 008173.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)3 Downloads (Pure) -
Biomarker qualification at the European Medicines Agency: a review of biomarker qualification procedures from 2008 to 2020
Bakker, E., Hendrikse, N. M., Ehmann, F., Van der Meer, D. S., Llinares Garcia, J., Vetter, T., Starokozhko, V. & Mol, P. G. M., jul-2022, In: Clinical Pharmacology & Therapeutics. 112, 1, blz. 69-80 12 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand4 Citaten (Scopus)35 Downloads (Pure) -
Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands
de Vries, E., Bakker, E., Monster, T. B. M., Denig, P. & Mol, P. G. M., 15-sep-2022, (E-pub ahead of print) In: Drug Safety. 12 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand -
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach
de Vries, E., Bakker, E., Francisca, R. D. C., Croonen, S., Denig, P. & Mol, P. G. M., 2022, In: Drug Safety. 45, 4, blz. 369–378 10 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand11 Downloads (Pure) -
How can a joint European health technology assessment provide an 'additional benefit' over the current standard of national assessments? Insights generated from a multi-stakeholder survey in hematology/oncology
Julian, E., Gianfrate, F., Sola-Morales, O., Mol, P., Bergmann, J-F., Salmonson, T., Hebborn, A., Grande, M. & Ruof, J., 2-jun-2022, In: Health economics review. 12, 1, 12 blz., 30.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)2 Downloads (Pure)
Activiteiten
-
Targeting NASH, what is the impact on cardiovascular outcomes? A regulator’s perspective
Peter G. M. Mol (Invited speaker)
feb-2018Activiteit: Academic presentation › Academic
-
Registries for post-licensing evidence generation.
Peter G. M. Mol (Invited speaker)
17-apr-2018 → 19-apr-2018Activiteit: Academic presentation › Academic
-
Drug Approval: what regulatory tools.
Peter G. M. Mol (Keynote speaker)
15-nov-2018Activiteit: Professional or public presentation › Popular
-
Drug Approval & patient preference elicitation.
Peter G. M. Mol (Invited speaker)
25-okt-2018 → 26-okt-2018Activiteit: Academic presentation › Academic
-
Regulatory knowledge transfer: experience from SCOPE and WEB-RADR
Peter G. M. Mol (Invited speaker)
apr-2018Activiteit: Professional or public presentation › Professional
Prijzen
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prijs: Other distinction › Academic
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-apr-2019
Prijs: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prijs: Other distinction › Academic
-
Among the most popular publications in Drug Safety in 2017
de Vries, Sieta (Recipient) & Mol, Peter (Recipient), 2017
Prijs: Other distinction › Academic